Revive Therapeutics Ltd (RVV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 233 | 1,856 | 784 | 414 | 355 |
| Operating Income | -233 | -1,856 | -784 | -414 | -355 |
| Interest Expense | 2 | 4 | 6 | 7 | 9 |
| Other Income | -2,350 | -12 | 19 | 30 | -829 |
| Pre-tax Income | -2,585 | -1,872 | -771 | -391 | -1,193 |
| Net Income Continuous | -2,585 | -1,872 | -771 | -391 | -1,193 |
| Net Income | $-2,585 | $-1,872 | $-771 | $-391 | $-1,193 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-2,583 | $-1,868 | $-765 | $-383 | $-1,183 |